← FDA DRUG APPROVALS

FDA ANDA · ANDA078138

PERINDOPRIL ERBUMINE

Sponsor: ANI PHARMS

APPLICATION
ANDA078138
TYPE
ANDA
ORIGINAL APPROVAL
2009-11-10
LATEST ACTION
2009-11-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PERINDOPRIL ERBUMINEDiscontinued
PERINDOPRIL ERBUMINE 8MG · TABLET · ORAL
PERINDOPRIL ERBUMINEDiscontinued
PERINDOPRIL ERBUMINE 2MG · TABLET · ORAL
PERINDOPRIL ERBUMINEDiscontinued
PERINDOPRIL ERBUMINE 4MG · TABLET · ORAL

Approval history

2009-11-10Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →